Treatment of Hypoalbuminemia

Understanding Hypoalbuminemia

• Hypoalbuminemia is common in acute and chronic illness and is associated with greater morbidity compared to patients with preserved albumin levels 1, 2
• In the postoperative period, serum albumin levels typically decrease by 10-15 g/L due to suppressed synthesis from inflammatory cytokines and transcapillary loss 2

Primary Treatment Approach

• The American College of Physicians recommends focusing on treating the underlying cause of hypoalbuminemia rather than the low albumin level itself 3
• Provide adequate nutritional support, especially in malnourished patients 3

Specific Clinical Scenarios Where Albumin Infusion May Be Considered

• Albumin infusion is suggested to prevent paracentesis-induced circulatory dysfunction in patients with liver disease complications undergoing large-volume paracentesis (>5L) 4, 3
• Albumin infusion is recommended for patients with spontaneous bacterial peritonitis 3

When Albumin Infusion Is Not Recommended

• The American Thoracic Society suggests that intravenous albumin is not recommended for first-line volume replacement or to increase serum albumin levels in critically ill adult patients (excluding thermal injuries and ARDS) 4, 1, 2
• Albumin is not suggested for volume replacement or to increase serum albumin level in critically ill patients with thermal injuries or ARDS 4
• Albumin infusion is not recommended in conjunction with diuretics for removal of extravascular fluid 4
• Albumin infusion is not recommended for preterm neonates with respiratory distress and low serum albumin levels 4
• Albumin infusion is not recommended for patients undergoing kidney replacement therapy for prevention or treatment of intradialytic hypotension 4
• Albumin infusion is not recommended for pediatric patients undergoing cardiovascular surgery 4

Cautions

• Albumin infusion is expensive (approximately $130/25g USD) and has potential adverse effects including fluid overload, hypotension, hemodilution requiring RBC transfusion, anaphylaxis, and peripheral gangrene 2

Management of Hypoalbuminemia

Definition and Significance

• Hypoalbuminemia is a valid and clinically useful measure of protein-energy nutritional status in patients with chronic conditions such as kidney disease, according to the American Journal of Kidney Diseases guidelines 5

Specific Clinical Thresholds for Intervention

Surgical Patients

• Hypoalbuminemia <30 g/L is associated with higher risk of postoperative intra-abdominal sepsis in inflammatory bowel disease patients, as reported by Gut 6, 7
• Preoperative albumin assessment is recommended for risk stratification in cardiac surgery patients (Class IIa, level C-LD), as suggested by the American Heart Association 8
• Correction of nutritional deficiency is recommended when feasible before cardiac surgery (Class IIa, level C-LD), according to the American Heart Association 8

Liver Disease

• In hospitalized patients with decompensated cirrhosis, hyperoncotic albumin to target a level >30 g/L showed no improvement in outcomes (infections, kidney dysfunction, or death) compared to no albumin, as found by Chest 9, 10

Chronic Kidney Disease

• A predialysis or stabilized serum albumin equal to or greater than the lower limit of the normal range (approximately 4.0 g/dL for the bromcresol green method) is the outcome goal, as recommended by the National Kidney Foundation 5

Recommended Approach to Hypoalbuminemia

• Identifying and treating the underlying cause of hypoalbuminemia, such as inflammation, malnutrition, or protein loss, is crucial, as emphasized by Gut and the American Journal of Kidney Diseases 5, 7
• Providing nutritional support is especially important in malnourished patients, as highlighted by Gut 6
• Albumin infusion may be considered in specific scenarios, such as spontaneous bacterial peritonitis, as noted by Chest 10
• Regular assessment of serum albumin levels is necessary to monitor for improvement, as recommended by the American Journal of Kidney Diseases 5

Treatment of Hypoalbuminemia

Fluid Resuscitation

• The fluid balance was lower in patients receiving albumin compared to crystalloids in sepsis patients 11

Prognosis

• A meta-analysis found that a decrease of 1.0 g/dL in serum albumin increased the odds of morbidity by 89% and of mortality by 137% 12

Steroid-Induced Hypoalbuminemia

Mechanism and Clinical Significance

• Corticosteroids increase net loss of protein in both children and adults with Crohn's disease, contributing to hypoalbuminemia 13
• Steroids drive catabolism and cause anorexia and nausea, which can worsen nutritional status and further reduce albumin levels 13
• The inflammatory burden from underlying conditions being treated with steroids can independently reduce serum albumin concentrations 13
• Patients with inflammatory bowel disease on steroids are particularly susceptible to hypoalbuminemia due to the combined effects of inflammation, malnutrition, and steroid-induced catabolism 13

Prevention and Management

• Use steroids for the shortest time possible with downward titration of the dose whenever feasible, as recommended by the National Comprehensive Cancer Network 14
• Monitor for nutritional status in patients requiring long-term steroid therapy, according to the Journal of Crohn's and Colitis 13
• Be aware that steroid-induced hypoalbuminemia may be exacerbated in patients with active inflammatory conditions 13

Albumin Infusion Threshold for Hypoalbuminemia

Clinical Decision Framework for Albumin Infusion

• The threshold for initiating albumin infusion in patients with hypoalbuminemia is generally when serum albumin levels fall below 2.5 g/dL, particularly when associated with clinical symptoms of hypovolemia or in specific clinical conditions 15
• Serum albumin <2.5 g/dL is considered a predictor of severe disease in many clinical contexts 15

Specific Clinical Scenarios Where Albumin Infusion Is Indicated

• Albumin infusion is indicated for patients with symptomatic hypovolemia, characterized by clinical signs such as prolonged capillary refill time, tachycardia, hypotension, and oliguria 16
• In congenital nephrotic syndrome, daily albumin infusions of 1-4 g/kg may be initiated, with frequency and dosage based on clinical indicators of hypovolemia 16
• The American Journal of Kidney Diseases suggests that serum albumin concentration should be monitored regularly, with a stable or rising value as the goal, and evaluated in the context of the patient's overall clinical status including comorbid diseases 17, 18

Administration and Monitoring Guidelines

• For dialysis patients, a predialysis or stabilized serum albumin equal to or greater than the lower limit of normal range (approximately 4.0 g/dL) is the outcome goal, as recommended by the American Journal of Kidney Diseases 19, 20
• Serum albumin may be a marker of inflammation rather than nutritional status in many acute conditions, as noted in Clinical Nutrition 21

Management of Hypoalbuminemia in Dialysis Patients

Understanding Hypoalbuminemia in Dialysis Patients

• Low serum albumin is a strong predictor of mortality and morbidity in dialysis patients, and treating the underlying causes rather than just correcting the albumin level is the recommended approach by the American Journal of Kidney Diseases 22, 23
• The highest albumin level possible should be the goal for each patient, with a target of at least 4.0 g/dL (using bromcresol green method), as suggested by the American Journal of Kidney Diseases 23, 24

First-Line Management Approach

• Ensure adequate nutrition monitored by a renal dietitian, as recommended by the American Journal of Kidney Diseases 22
• Prevent and treat catabolic illness, as recommended by the American Journal of Kidney Diseases 22
• Maintain adequate dialysis clearance (Kt/Vurea), as recommended by the American Journal of Kidney Diseases 22
• Address inflammation when present, as recommended by the American Journal of Kidney Diseases 25
• Aim for a protein intake of 1.2-1.3 g/kg body weight/day in clinically stable chronic peritoneal dialysis patients, as recommended by the American Journal of Kidney Diseases 22
• Monitor normalized protein nitrogen appearance (nPNA) with a target of ≥0.9 g/kg/day, as recommended by the American Journal of Kidney Diseases 22

Special Considerations for High Urea Levels

• In patients with high urea levels, the priority should be effective dialysis to remove the excess urea rather than albumin administration, as recommended by the American Journal of Kidney Diseases 22, 23

Monitoring Recommendations

• Monitor serum albumin concentration regularly (at least every 4 months), as recommended by the American Journal of Kidney Diseases 23
• Evaluate serum albumin levels in the context of the patient's overall clinical status, as recommended by the American Journal of Kidney Diseases 23
• Consider measuring positive acute-phase proteins (e.g., C-reactive protein) to identify inflammation in patients with low serum albumin, as recommended by the American Journal of Kidney Diseases 25

Treatment of Hypoalbuminemia

Common Pitfalls

• Assuming hypoalbuminemia is solely due to nutritional deficiency when inflammation may be the primary driver, as suggested by research published in 2003 26

Management of Hypoalbuminemia

Severity Classification and Clinical Significance

• Serum albumin <3.0 g/dL is associated with increased risk of surgical complications, including surgical site infections and poor wound healing, according to the American College of Surgeons and the European Society for Clinical Nutrition and Metabolism 27, 28
• Hypoalbuminemia <3.0 g/dL is considered a significant surgical risk factor and reflects disease-associated catabolism and disease severity, as stated by the European Society for Clinical Nutrition and Metabolism 28

Primary Treatment Approach

• Provide adequate nutritional support, especially in malnourished patients, with protein intake of 1.2-1.3 g/kg body weight/day, as recommended by the European Society for Clinical Nutrition and Metabolism 28

When to Consider Albumin Infusion

• Albumin infusion should be considered in patients with large-volume paracentesis (>5L) in cirrhotic patients at a dose of 8g albumin/L of ascites removed, as recommended by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases 29, 30
• Albumin infusion is recommended in patients with spontaneous bacterial peritonitis with increased serum creatinine, as stated by the European Association for the Study of the Liver 29

Special Considerations for Specific Conditions

Surgical Patients

• Preoperative nutritional assessment and optimization is recommended for patients with albumin <3.0 g/dL, according to the American College of Surgeons and the European Society for Clinical Nutrition and Metabolism 27, 28

Cirrhosis and Ascites

• Albumin infusion is recommended after large-volume paracentesis (>5L) at 8g/L of ascites removed, as recommended by the European Association for the Study of the Liver 29
• In spontaneous bacterial peritonitis with increased creatinine, albumin infusion is recommended, as stated by the European Association for the Study of the Liver 29

Hypoalbuminemia Correction Guideline

Pathophysiology and Primary Treatment Strategy

• Inflammatory cytokines directly downregulate hepatic albumin synthesis, even when protein and caloric intake are adequate, in patients with hypoalbuminemia 31
• Multiple non-nutritional factors, including age, comorbidities, and external protein losses, affect serum albumin levels in patients with hypoalbuminemia 31
• Treating active inflammation is a priority, as it is often a more powerful predictor of poor outcomes than low albumin itself, in patients with hypoalbuminemia 31
• Correcting fluid overload is essential, as hemodilution from excess fluid decreases serum albumin concentration, in patients with hypoalbuminemia 31
• Minimizing external protein losses by treating proteinuria or reducing dialysate losses is crucial, in patients with hypoalbuminemia 31

Monitoring and Treatment

• Measuring C-reactive protein or other inflammatory markers can help distinguish inflammation-driven hypoalbuminemia from pure malnutrition, in patients with hypoalbuminemia 31
• Targeting a serum albumin ≥4.0 g/dL (using bromcresol green method) is recommended, in dialysis patients with hypoalbuminemia 31

Management of Hypoalbuminemia with Intravenous Albumin

Indications for IV Albumin

• The American Association for the Study of Liver Diseases recommends administering 8 grams of albumin per liter of ascitic fluid removed during large-volume paracentesis to prevent post-paracentesis circulatory dysfunction 32
• The American Association for the Study of Liver Diseases suggests giving 1.5 g/kg body weight on day 1 and 1.0 g/kg on day 3 for spontaneous bacterial peritonitis, which reduces acute kidney injury and mortality 32
• For Stage 2-3 acute kidney injury in cirrhosis with ascites, the European Association for the Study of the Liver recommends withdrawing diuretics immediately and administering 1 g/kg body weight albumin daily for 2 consecutive days 33

Dosage and Administration

• The American Association for the Study of Liver Diseases recommends using 6-8 g/L of albumin in patients with acute-on-chronic liver failure, regardless of the volume removed 32
• For patients with spontaneous bacterial peritonitis, those with serum bilirubin >4 mg/dL or baseline creatinine >1.0 mg/dL benefit most from albumin administration 32

Contraindications and Precautions

• The American College of Chest Physicians recommends against using IV albumin as first-line volume replacement in critically ill patients, excluding specific liver disease scenarios 34
• The American Association for the Study of Liver Diseases advises against using albumin for other infections in cirrhosis, as it increases pulmonary edema without benefit 32

Dietary Management of Hypoalbuminemia

Introduction to Hypoalbuminemia Management

• The American Journal of Kidney Diseases recommends ensuring adequate protein intake of 1.2-1.3 g/kg body weight per day, combined with sufficient caloric intake (30-35 kcal/kg/day), while simultaneously treating the underlying inflammatory or disease process causing the low albumin 35

Protein Intake Targets

• The National Kidney Foundation suggests that hemodialysis patients require at least 1.2 g protein/kg/day 35
• Peritoneal dialysis patients require at least 1.3 g protein/kg/day due to protein losses in dialysate 35
• Acutely ill or hospitalized patients should increase protein intake to 1.2-1.3 g/kg/day minimum 35

Recommended High-Protein Foods

• Lean meats, such as chicken breast, turkey, lean beef, and pork tenderloin, are recommended as high-protein food sources 35
• Fish and seafood, including salmon, tuna, cod, and shrimp, provide 20-25g protein per 3-4 oz serving 35
• Eggs, dairy products, legumes, soy products, and nuts and seeds are also recommended as high-protein food sources 35

Essential Caloric Intake

• Patients under 60 years require a minimum of 35 kcal/kg/day, while patients 60 years and older require 30-35 kcal/kg/day 35
• Energy intake of less than 188 kcal/day is associated with negative nitrogen balance in dialysis patients 35

Management of Recurrent Hypoalbuminemia

Treatment of Hepatorenal Syndrome-AKI

• The American Association for the Study of Liver Diseases recommends administering 1 g/kg of albumin on day 1 followed by 20-40 g daily along with vasoactive agents for the treatment of hepatorenal syndrome-AKI, and continuing until serum creatinine returns to within 0.3 mg/dL of baseline for 2 consecutive days or for a maximum of 14 days 36

Management of Hypoalbuminemia

Condition-Specific Management Approaches

• The American Academy of Pediatrics and the National Kidney Foundation recommend daily albumin infusions of 1-4 g/kg for congenital nephrotic syndrome, based on clinical indicators of hypovolemia rather than serum albumin levels alone 37
• The International Society of Nephrology suggests that anticoagulation considerations in nephrotic syndrome with hypoalbuminemia should include assessing venous thromboembolism risk and considering prophylactic anticoagulation with warfarin if high risk and low bleeding risk, with frequent monitoring of international normalized ratio 37

Nutritional Support Recommendations

• The National Institute of Diabetes and Digestive and Kidney Diseases recommends high-protein food sources, including lean meats, fish and seafood, eggs, dairy products, legumes, soy products, nuts and seeds, to help manage hypoalbuminemia 37

Critical Thresholds and Risk Stratification

• The American College of Surgeons recommends that serum albumin <3.0 g/dL is associated with increased risk of postoperative complications, including surgical site infections and poor wound healing, and preoperative nutritional assessment and optimization is recommended 37
• The European Society of Parenteral and Enteral Nutrition suggests that serum albumin <2.5 g/dL should be considered for albumin infusion only in specific clinical scenarios with symptomatic hypovolemia 37

Evaluation and Management of Mild Hypoalbuminemia with Lower‑Extremity Edema

Diabetes‑Related Kidney Disease

• In patients with diabetes, an early albumin‑to‑creatinine ratio (UACR) ≥ 30 mg/g is associated with mild hypoalbuminemia (≈ 3.4 g/dL) and peripheral edema, indicating diabetic kidney disease as a potential cause. 38, 39
• Reduced estimated glomerular filtration rate (eGFR) in diabetic individuals correlates with mild hypoalbuminemia and edema, supporting renal dysfunction as an etiologic factor. 38, 39
• The presence of diabetic retinopathy in type 2 diabetes further supports microvascular complications contributing to albumin loss and edema; its absence in type 1 diabetes suggests alternative renal pathology. 39

Chronic Venous Insufficiency

• Chronic venous insufficiency can produce unilateral or bilateral lower‑extremity edema despite normal albumin or only mild hypoalbuminemia, and clinical signs include varicose veins, hyperpigmentation, and lipodermatosclerosis. 40

Inflammation‑Driven Edema Assessment

• Elevated C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR) identifies inflammation‑driven hypoalbuminemia and should be measured early in the work‑up of edema. 41
• The detection of ascites or pulmonary edema alongside mild hypoalbuminemia suggests systemic volume overload and warrants further cardiac or hepatic evaluation. 42

Albumin Infusion Indications

• Routine albumin infusion is not recommended for uncomplicated hypoalbuminemia (serum albumin ≈ 3.4 g/dL) or for volume replacement in non‑cirrhotic patients. 42
• Albumin infusion is indicated in cirrhosis when large‑volume paracentesis exceeds 5 L, with a dosing regimen of 8 g albumin per liter of ascites removed. 42
• Albumin infusion is also indicated for spontaneous bacterial peritonitis with elevated creatinine, using 1.5 g/kg on day 1 followed by 1.0 g/kg on day 3. 42
• In symptomatic hypovolemia with serum albumin < 2.5 g/dL and clinical signs of poor perfusion, albumin replacement may be considered. 42

Edema Management Strategies

• For patients with true volume overload (adequate perfusion, hypertension), sodium restriction to < 2 g/day and loop diuretics (starting 20–40 mg furosemide daily) are recommended, with monitoring of daily weight, intake/output, electrolytes, and kidney function. 39

Diagnostic Testing Recommendations

• Complete blood count testing can uncover infection or malignancy as underlying causes of edema in the context of mild hypoalbuminemia. 40
• Liver function testing helps identify hepatic congestion or cirrhosis as contributors to edema when albumin is low. 42